semaglutide and vitamin d Compounded GLP-1 (Semaglutide) Semaglutide 3 Vitamin D and Semaglutide: Safety

They are essential

FDA labels note that dehydration from gastrointestinal adverse effects can contribute to acute kidney injury in some cases

More than half of participants had type 2 diabetes, and about 75% had obesity

And compounded drugs, especially when produced en masse and in pharmacies with little or no FDA oversight, are also prone to both dosing errors and sterility issues

Starting at 0.25 mg allows the body to adapt to GLP-1 signaling

Baseline kidney function testing before initiating either substance, with periodic monitoring based on individual risk factors, represents prudent clinical practice, particularly in patients with diabetes or other kidney disease risk factors